Scarica l'app Stockscreener
30.69
3.26%
0.97
Dopo l'orario di chiusura:
30.69
Alamar Biosciences Inc Borsa (ALMR) Ultime notizie
Form 4 Alamar Biosciences: Qiming Corporate GP VI, Ltd. (10% Owner) For: 19 October - Investing.com Canada
Four Qiming holders sold 173,673 Alamar Biosciences (ALMR) shares on October 15–16, 2026. - Stock Titan
Form 144 Alamar Biosciences For: 14 October By Investing.com - Investing.com Nigeria
Form 144 Alamar Biosciences For: 14 October By Investing.com - Investing.com UK
J.P. Morgan is broker for an affiliate’s proposed share sale at Alamar Biosciences (ALMR). - Stock Titan
An affiliate proposes selling 1.56M shares of Alamar Biosciences (Nasdaq: ALMR). - Stock Titan
An affiliate proposes selling 41,945 Alamar Biosciences (ALMR) shares through J.P. Morgan Securities LLC. - Stock Titan
Certain Class B Common Stock of Alamar Biosciences, Inc. are subject to a Lock-Up Agreement Ending on 14-OCT-2026. - www.marketscreener.com
Alamar Biosciences Names Former Grail CEO Bob Ragusa to Board of Directors and Expands Leadership Team - The Manila Times
Alamar Biosciences Names Former Grail CEO Bob Ragusa to Board of Directors and Expands Leadership Team - www.marketscreener.com
Alamar Biosciences Study in The Lancet Neurology Finds Distinct Biomarker Responses to Lecanemab in Early Alzheimer’s Disease - Quiver Quantitative
Lancet Neurology Study Using Alamar Biosciences’ Technology Reveals Divergent Biological Responses to Alzheimer’s Treatment - GlobeNewswire Inc.
Why is Alamar Biosciences stock surging today? By Investing.com - Investing.com Nigeria
Mistras Group, Strategy, Hyperliquid Strategies And Other Big Stocks Moving Higher On Friday - benzinga.com
Ragusa Robert P. Acquires 5,686 Shares and 25,599 Derivative Securities of Alamar Biosciences - Kalkine Media
Alamar Biosciences (ALMR) director has no reported share holdings - Stock Titan
Alamar Biosciences (ALMR) director gets new RSUs and stock option grant - Stock Titan
Alamar Biosciences Slides After Conference Hype Fades - TipRanks
Alamar Biosciences to Participate in Morgan Stanley 24th Annual Global Healthcare Conference - manilatimes.net
Alamar Biosciences to Participate in Morgan Stanley 24th Annual Global Healthcare Conference - GlobeNewswire
Alamar Biosciences, Inc. Announces Appointment of Robert Ragusa as Director and Member of Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee, Effective September 1, 2026 - marketscreener.com
Alamar Biosciences expands proteomics partnership by 86,000 samples - Investing.com Nigeria
Valion Bio Announces Reverse Stock Split - Yahoo Finance
Alamar Biosciences Stock: Promising But Expensive Proteomics Growth (NASDAQ:ALMR) - Seeking Alpha
Alamar Stock: The Content Flywheel Is More Valuable Than The Instrument (ALMR) - Seeking Alpha
Alamar Biosciences (ALMR) Stock Price Jumps As Margin Gains Meet Loss Pressure - Sahm
Alamar Biosciences (ALMR): Yuling Luo discloses 6.4% beneficial ownership stake - Stock Titan
Alamar Biosciences, Inc. (ALMR) Q2 2026 Earnings ReportResults, Call & Slides - TipRanks
Alamar Biosciences, Inc. (ALMR) Q2 2026 Earnings ReportResults, Call & Slides - tipranks.com
Alamar Biosciences, Inc. Common Stock (NASDAQ: ALMR) Stock Price, News & Analysis - kalkine.ca
Alamar Biosciences, Inc. Common Stock (NASDAQ: ALMR) Stock Price, News & Analysis - Kalkine
Analysts Offer Insights on NA Companies: Alamar Biosciences, Inc. (ALMR), NIQ Global Intelligence PLC (NIQ) and Amentum Holdings, Inc. (AMTM) - The Globe and Mail
Analysts Offer Insights on NA Companies: Alamar Biosciences, Inc. (ALMR), NIQ Global Intelligence PLC (NIQ) and Amentum Holdings, Inc. (AMTM) - theglobeandmail.com
Alamar Biosciences Shares (ALMR) Surge 31% as Consumables Drive Gross Margin Up - TechStock²
Alamar Biosciences (ALMR): Qiming funds report over 10% ownership stake - Stock Titan
Alamar Biosciences launches NULISAseq Immune 340 Panel for profiling - scanx.trade
Alamar Biosciences Q2 Results: Revenue Rises 82% To $29.4 Million - scanx.trade
Stifel raises Alamar Biosciences stock price target on earnings beat By Investing.com - Investing.com Canada
Alamar Biosciences Reports Q2 2026 Financial Results in Form 10-Q Filing - Kalkine Media
ALAMAR BIOSCIENCES INC : STIFEL RAISES TARGET PRICE TO $32 FROM $28 - Bitget
Alamar Biosciences Q2 2026 Earnings Call Transcript - MarketBeat
Alamar Biosciences, Inc. Stock 12‑Month Price Target Raised to $33.4, Implies 19% Upside - TradingView
Alamar Biosciences, Inc. 2Q 2026: Revenue $29.4M, EPS $(0.22) — 10-Q Summary - TradingView
Stifel raises Alamar Biosciences stock price target on earnings beat - Investing.com
Big Sky Industrial Inc. Common Stock Q2 Earnings Call Highlights - Yahoo Finance
Alamar Biosciences Inc (ALMR) (Q2 2026) Earnings Call Highlights: Revenue Surges 82% on 147% ... - Yahoo Finance Singapore
Alamar Biosciences (ALMR) Stock Trades At A Premium To Its Sales - Yahoo Finance
Alamar Biosciences to report Q2 2026 results on August 10, 2026 - scanx.trade
Form 8K Alamar Biosciences For: 10 August By Investing.com - Investing.com Nigeria
Alamar Biosciences Q2 Earnings Call Highlights - MarketBeat
2.13%
3.76%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):